Fierce Drug Safety Week 2021 has ended
avatar for Sherice Mills

Sherice Mills

Jazz Pharmaceuticals
Sr. Director, Benefit-Risk Management
Introducing Risk Evaluation and Mitigation Strategies (REMS) enthusiast, Sherice Mills, who has had the
opportunity to work on many of the industry’s shared REMS programs in place today. She is a Senior
Director and currently leads the Benefit Risk Management group at Jazz Pharmaceuticals, Inc. Sherice is
one of the six founding members of the newly establish REMS Industry Consortium (RIC) that will work
across the industry to identify and promote best practices. Sherice has worked in the REMS space since
its inception in 2007 and has an expansive involvement with the development and implementation of
both single and shared REMS systems and operations. She has engaged with the FDA for REMS
programs many times throughout the years. Managing one of the more complex programs in operation
today, has provided her numerous opportunities to address different nuances and unique facets of
REMS that not all programs will experience. Opportunities to learn different approaches and new
solutions to existing challenges is one of the more inviting reasons she continues to explore
opportunities for advancement in patient safety through REMS.

My Speakers Sessions

Tuesday, January 19

11:15am EST